Annual Shareholders Equity
$431.75 M
+$31.34 M+7.83%
December 31, 2023
Summary
- As of February 24, 2025, ACAD annual stockholders equity is $431.75 million, with the most recent change of +$31.34 million (+7.83%) on December 31, 2023.
- During the last 3 years, ACAD annual shareholders equity has fallen by -$195.25 million (-31.14%).
- ACAD annual shareholders equity is now -38.24% below its all-time high of $699.13 million, reached on December 31, 2019.
Performance
ACAD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$577.18 M
+$60.48 M+11.71%
September 30, 2024
Summary
- As of February 24, 2025, ACAD quarterly stockholders equity is $577.18 million, with the most recent change of +$60.48 million (+11.71%) on September 30, 2024.
- Over the past year, ACAD quarterly shareholders equity has increased by +$215.01 million (+59.37%).
- ACAD quarterly shareholders equity is now -17.44% below its all-time high of $699.13 million, reached on December 31, 2019.
Performance
ACAD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACAD Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.8% | +59.4% |
3 y3 years | -31.1% | +1.8% |
5 y5 years | -9.9% | -16.3% |
ACAD Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -20.2% | +7.8% | at high | +59.4% |
5 y | 5-year | -38.2% | +7.8% | -17.4% | +59.4% |
alltime | all time | -38.2% | +919.7% | -17.4% | +1088.1% |
ACADIA Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $577.18 M(+11.7%) |
Jun 2024 | - | $516.70 M(+11.3%) |
Mar 2024 | - | $464.04 M(+7.5%) |
Dec 2023 | $431.75 M(+7.8%) | $431.75 M(+19.2%) |
Sep 2023 | - | $362.17 M(-8.5%) |
Jun 2023 | - | $395.79 M(+5.8%) |
Mar 2023 | - | $374.26 M(-6.5%) |
Dec 2022 | $400.41 M(-26.0%) | $400.41 M(-5.9%) |
Sep 2022 | - | $425.69 M(-2.1%) |
Jun 2022 | - | $434.85 M(-2.2%) |
Mar 2022 | - | $444.80 M(-17.8%) |
Dec 2021 | $540.89 M(-13.7%) | $540.89 M(-4.6%) |
Sep 2021 | - | $566.96 M(+0.4%) |
Jun 2021 | - | $564.84 M(-2.9%) |
Mar 2021 | - | $581.61 M(-7.2%) |
Dec 2020 | $627.01 M(-10.3%) | $627.01 M(-4.3%) |
Sep 2020 | - | $654.87 M(-1.2%) |
Jun 2020 | - | $663.01 M(+3.9%) |
Mar 2020 | - | $638.38 M(-8.7%) |
Dec 2019 | $699.13 M(+45.9%) | $699.13 M(+1.4%) |
Sep 2019 | - | $689.29 M(+77.2%) |
Jun 2019 | - | $388.91 M(-7.0%) |
Mar 2019 | - | $418.36 M(-12.7%) |
Dec 2018 | $479.08 M(+42.9%) | $479.08 M(+114.4%) |
Sep 2018 | - | $223.44 M(-15.6%) |
Jun 2018 | - | $264.72 M(-13.0%) |
Mar 2018 | - | $304.17 M(-9.3%) |
Dec 2017 | $335.29 M(-35.3%) | $335.29 M(-11.1%) |
Sep 2017 | - | $377.33 M(-9.1%) |
Jun 2017 | - | $415.14 M(-9.3%) |
Mar 2017 | - | $457.52 M(-11.7%) |
Dec 2016 | $518.41 M(+159.5%) | $518.41 M(-10.3%) |
Sep 2016 | - | $578.06 M(+41.4%) |
Jun 2016 | - | $408.81 M(-8.2%) |
Mar 2016 | - | $445.25 M(+122.9%) |
Dec 2015 | $199.76 M(-35.5%) | $199.76 M(-12.1%) |
Sep 2015 | - | $227.35 M(-11.1%) |
Jun 2015 | - | $255.82 M(-10.3%) |
Mar 2015 | - | $285.09 M(-7.9%) |
Dec 2014 | $309.49 M(+69.9%) | $309.49 M(-6.4%) |
Sep 2014 | - | $330.49 M(-5.6%) |
Jun 2014 | - | $350.11 M(-4.2%) |
Mar 2014 | - | $365.46 M(+100.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | $182.13 M(+114.3%) | $182.13 M(+0.8%) |
Sep 2013 | - | $180.75 M(-0.4%) |
Jun 2013 | - | $181.47 M(+127.8%) |
Mar 2013 | - | $79.66 M(-6.3%) |
Dec 2012 | $84.98 M(+263.8%) | $84.98 M(+381.1%) |
Sep 2012 | - | $17.66 M(+39.0%) |
Jun 2012 | - | $12.71 M(-27.7%) |
Mar 2012 | - | $17.59 M(-24.7%) |
Dec 2011 | $23.36 M(-21.3%) | $23.36 M(-17.0%) |
Sep 2011 | - | $28.14 M(-14.3%) |
Jun 2011 | - | $32.82 M(-13.9%) |
Mar 2011 | - | $38.11 M(+28.4%) |
Dec 2010 | $29.69 M(+145.1%) | $29.69 M(<-9900.0%) |
Sep 2010 | - | -$174.00 K(-105.5%) |
Jun 2010 | - | $3.16 M(-55.5%) |
Mar 2010 | - | $7.10 M(-41.4%) |
Dec 2009 | $12.11 M(-77.1%) | $12.11 M(-36.1%) |
Sep 2009 | - | $18.97 M(-28.2%) |
Jun 2009 | - | $26.41 M(-31.2%) |
Mar 2009 | - | $38.39 M(-27.6%) |
Dec 2008 | $52.99 M(-53.5%) | $52.99 M(-20.0%) |
Sep 2008 | - | $66.24 M(-18.4%) |
Jun 2008 | - | $81.20 M(-17.7%) |
Mar 2008 | - | $98.67 M(-13.4%) |
Dec 2007 | $113.93 M(+69.6%) | $113.93 M(-12.2%) |
Sep 2007 | - | $129.73 M(-10.1%) |
Jun 2007 | - | $144.27 M(+154.0%) |
Mar 2007 | - | $56.80 M(-15.4%) |
Dec 2006 | $67.16 M(+70.6%) | $67.16 M(-14.3%) |
Sep 2006 | - | $78.40 M(-11.5%) |
Jun 2006 | - | $88.55 M(+122.1%) |
Mar 2006 | - | $39.86 M(+1.2%) |
Dec 2005 | $39.37 M(+28.3%) | $39.37 M(-20.0%) |
Sep 2005 | - | $49.20 M(-19.5%) |
Jun 2005 | - | $61.15 M(+88.9%) |
Mar 2005 | - | $32.37 M(+5.5%) |
Dec 2004 | $30.68 M(-158.2%) | $30.68 M(-17.9%) |
Sep 2004 | - | $37.36 M(-12.7%) |
Jun 2004 | - | $42.79 M(-173.3%) |
Mar 2004 | - | -$58.42 M(+10.9%) |
Dec 2003 | -$52.67 M(+31.4%) | -$52.67 M |
Dec 2002 | -$40.09 M(-324.4%) | - |
Dec 2001 | $17.86 M(-179.4%) | - |
Dec 2000 | -$22.51 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual shareholders equity year-on-year change?
- What is ACADIA Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly shareholders equity year-on-year change?
What is ACADIA Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ACAD is $431.75 M
What is the all time high annual shareholders equity for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual stockholders equity is $699.13 M
What is ACADIA Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ACAD annual stockholders equity has changed by +$31.34 M (+7.83%)
What is ACADIA Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ACAD is $577.18 M
What is the all time high quarterly shareholders equity for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly stockholders equity is $699.13 M
What is ACADIA Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ACAD quarterly stockholders equity has changed by +$215.01 M (+59.37%)